| Similar Articles |
|---|
 |
The Motley Fool
July 18, 2011
Rich Smith |
Carl Icahn's Clorox Pipedream Icahn announced that he wants to up his 9.4% stake in Clorox, bidding to buy the whole company for $76.50 per share.   |
The Motley Fool
July 22, 2011
Evan Niu |
Clorox to Icahn: "It's Not You, It's Me" Clorox announces that its board has unanimously rejected Icahn's unsolicited bid to acquire the company. |
The Motley Fool
August 22, 2011
Jeff Bailey |
Fending Off Icahn, Clorox Takes It Out on Consumers With Big Price Hikes Does Clorox still look like a bargain? |
The Motley Fool
October 24, 2011 |
A Brief History of Clorox's Returns Clorox shares returned 145% over the past decade. How'd they get there? |
The Motley Fool
October 22, 2010
Anand Chokkavelu |
3 Brand-Name Stocks Near 52-Week Lows Here are the top three companies in the brand name space (by market cap) that are hugging 52-week lows: Colgate-Palmolive... Kimberly-Clark... Clorox... |
The Motley Fool
September 3, 2010
Matt Koppenheffer |
How Much Is Clorox Worth? Clorox is a stable company with a portfolio of strong brands, opportunity to grow both domestically and internationally, and its stock may be on sale right now. |
The Motley Fool
January 12, 2011
Andrew Bond |
This Stock Is a Lot Sexier Than You Think While Clorox's products bore many, its returns are more exciting. |
The Motley Fool
March 14, 2006
Seth Jayson |
P&G Gets Nicked Procter & Gamble shares dropped 2.5% after the firm released EPS guidance that didn't quite meet Wall Street's fancy. Investors, too bad the blip's not bigger. |
The Motley Fool
May 20, 2005
Steven Mallas |
Clorox: A Fresh Idea? Clorox has a nice history of long-term performance -- but should you buy it now? |
The Motley Fool
October 20, 2005 |
Understanding "Multiples" Multiples can help you evaluate stock prices. Here's what they mean. |
The Motley Fool
August 13, 2010
Ilan Moscovitz |
Procter & Gamble: Dividend Dynamo or Disaster? Just how safe is this dividend? |
The Motley Fool
June 17, 2004
Steven Mallas |
Clorox's Bright-White Guidance Clorox not only supplies products that keep your clothes clean and fresh but it can also deliver some crisp earnings as well. |
The Motley Fool
July 10, 2009
Dan Caplinger |
6 Dividend Stocks You Can Depend On Lately, trying to find good dividend stocks has been like walking in a minefield. You never know when the next dividend blowup is going to do some serious damage to your portfolio. These six all have traits you want to look for. |
The Motley Fool
January 17, 2012
Matt Koppenheffer |
What's Ahead for Procter & Gamble in 2012? Procter & Gamble is a dividend stalwart and an investor favorite. But what can investors expect next? |
The Motley Fool
February 7, 2005
Stephen D. Simpson |
Bright, But Not Bold, Clorox Steady but unspectacular growth might leave investors wanting a bit more kick. |
The Motley Fool
December 19, 2005
Seth Jayson |
Clorox Brightens Forecast Clorox's guidance is a bit better. That may be enough to make the shares cheap. Investors on the lookout for a premium company at a bargain price may not have to wait much longer. |
The Motley Fool
June 13, 2006
Nathan Parmelee |
Bargains in the Cupboard "Buy what you know" is truer than you think. Procter & Gamble... Clorox... Church & Dwight... Colgate-Palmolive... |
The Motley Fool
February 7, 2011
Matt Koppenheffer |
A Messy Quarter for This Bleach Baron It wasn't a pretty quarter for Clorox, but the future may look a bit brighter. |
The Motley Fool
August 4, 2010
Matt Koppenheffer |
Clorox? More Like Snore-ox! Clorox announces its fiscal fourth-quarter and full-year earnings. |
The Motley Fool
April 12, 2010
Rick Steier |
Clorox: When a Stalwart Lets You Down Clorox is a waste of an investment. |
The Motley Fool
March 30, 2011
Anders Bylund |
Mentor Could Use Some Guidance Is the company looking to preserve shareholder interest or management paychecks? |
The Motley Fool
May 4, 2011
Matt Koppenheffer |
Clorox Is Yet Another Victim Higher commodity costs are chipping away at margins. |
The Motley Fool
November 7, 2005
Jeremy MacNealy |
Can Clorox Remove This Stain? Clorox is a solid company in many ways, but it competes with consumer goods rivals and struggles with increased energy-related costs. Investors, take note. |
The Motley Fool
August 6, 2004
Seth Jayson |
Clorox Looks Clean Enough At this price, the company looks fairly priced, but there's much to be said for steady, cash-churning juggernauts, especially in a market such as this. |
The Motley Fool
March 31, 2010
Mike Pienciak |
Is P&G Finally A Buy? Valuation estimates bode well for shareholder returns. |
The Motley Fool
February 8, 2011
Todd Wenning |
Dividend Report Card: Colgate-Palmolive Does this household products giant's dividend pass the test? |
The Motley Fool
September 19, 2008
Joe Magyer |
Dismantling the PEG Ratio Breaking down a broken-down metric. |
The Motley Fool
June 16, 2009
Mike Pienciak |
Earn a Tidy Profit With Clorox Clorox's consumer reach extends to popular car-care products, cat litter, and that money-saving water pitcher in your fridge -- Brita. Its brands are market-share leaders in seven of the nine largest categories in which it competes. |
The Motley Fool
February 1, 2006
Rich Smith |
Foolish Forecast: Clorox Comes Clean Over the past four quarters, Clorox's rolling margin results have fallen consecutively in the gross, operating, and net categories. Investors, take note. |
The Motley Fool
December 6, 2011
Selena Maranjian |
Make Money in Low-P/E Stocks the Easy Way If you expect stocks with low P/E ratios to do well as they gradually rise in value, approaching more reasonable P/E levels, the Russell Low P/E ETF could save you a lot of trouble. |
The Motley Fool
August 19, 2005
Philip Durell |
How to Use the P/E The price-to-earnings ratio is a widely used -- and misused -- investing metric. Do you use it correctly? |
The Motley Fool
June 11, 2008
Brian Lawler |
He Said, Biogen Said Pharmaceutical Biogen Idec's battle with Carl Icahn is coming to a head. |
The Motley Fool
September 1, 2009
Rick Aristotle Munarriz |
Icahn Handles the Truth at Yahoo! Carl Icahn has sold shares of struggling online giant Yahoo! in each of the past three trading days, enough to take his stake below 5%. |
The Motley Fool
February 2, 2007
Steven Mallas |
Clorox Cleans Up on Wall Street Clorox comes clean with its second-quarter numbers. Investors, this is a good candidate for a dollar-cost-averaging strategy within the environment of a long-term portfolio. |
The Motley Fool
December 15, 2010
Toby Shute |
This Corporate Raider Hasn't Lost His Touch Has Carl Icahn outsmarted Blackstone with his bid for utility company Dynegy? The tentative answer today appears to be yes. |
The Motley Fool
April 14, 2010
Mike Pienciak |
The Latest M&A Rumor Another batch of consumer brands could be up for sale. |
The Motley Fool
June 22, 2011 |
Here's What Carl Icahn Bought and Sold Last Quarter A look under the hood at what Carl Icahn was up to in the first three months of 2011. |
The Motley Fool
February 23, 2010
Brian Orelli |
Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year. |
The Motley Fool
June 21, 2010
Dave Mock |
A Big Upgrade for Clorox This bullish call comes from more than just one analyst. |
The Motley Fool
November 3, 2010 |
Don't Be Afraid of Heights: The One Thing You Need to Know About High P/E Ratios Companies with high P/E ratios are simply being rewarded for what the market sees as future profit potential. |
The Motley Fool
June 3, 2005
Selena Maranjian |
Your Friend, the P/E Ratio The P/E is informative, but don't rely on it too much. There are many other numbers to examine when studying a stock. |
The Motley Fool
January 18, 2011
Matt Koppenheffer |
Why Do Investors Hate This Stock? Investors seem to hate Clorox but there's no good reason why. |
The Motley Fool
October 14, 2005
M.D. Mitchell |
Don't Cry, Kimberly-Clark Can the Kleenex maker's strong cash flows drive long-term growth despite higher costs? |
The Motley Fool
October 12, 2011
John Maxfield |
A Bird's Eye View of the S&P 500 Seeing the market from afar can help you decide when and what to buy. |
The Motley Fool
December 5, 2007
Sham Gad |
Watch Out for the P/E Ratio While the P/E ratio is a very useful resource, its often-ignored limitations can sometimes catch smart investors off guard. Use it carefully and prudently. |
The Motley Fool
September 13, 2011
Dan Caplinger |
How the Wrong Stocks Can Get You in Trouble Price-to-earnings ratios only tell you part of the story. |
The Motley Fool
September 24, 2008
Brian Lawler |
Bristol-Myers Puts Icahn and ImClone to the Test Despite trying to project different intentions last week, pharma giant Bristol-Myers Squibb raised its bid for ImClone Systems. |
The Motley Fool
May 3, 2007
Steven Mallas |
Bleach: An Exciting Investment Thesis? Clorox had a bright third quarter. Investors, take note. |
The Motley Fool
May 6, 2005
Stephen D. Simpson |
Clorox Gets Bleached Out High commodity prices have stolen away growth and cash flow. |
The Motley Fool
September 28, 2011
Tamara Rutter |
A Recession-Proof Stock for Your Portfolio Is Procter & Gamble is a winning bet in a losing market? |
